People on these drugs lose 15-20% of their body weight over several months [2], which was previously achievable only with bariatric surgery
Compounded medications are not the same as, interchangeable with, or substitutes for any FDA-approved branded product, including Mounjaro or Zepbound (registered trademarks of Eli Lilly and Company)
Available from: Accessed March 09, 2021
In the landmark STEP clinical trials, patients using semaglutide at the 2.4mg weekly dose lost an average of 14.9% of body weight over 68 weeks significantly more than diet and exercise alone
Currently, the brand-name GLP-1 drugs are either available as an injection or an oral tablet
Mechanical allodynia and thermal hyperalgesia were evaluated in separate experiments in a time-dependent manner